Clindamycin Phosphate 1.0%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Clindamycin Phosphate 1.0%, covering 2017-07-18 to 2017-07-18. Get the full timeline:
Most recent: Clinical Trial Update: W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers [Phase 1]